Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Prostatic Neoplasms × Cytarabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Leukemia, Myeloid, Acute 485 Leukemia 245 Precursor Cell Lymphoblastic Leukemia-Lymphoma 195 Lymphoma 132 Myelodysplastic Syndromes 94 Burkitt Lymphoma 76 Lymphoma, Non-Hodgkin 73 Leukemia, Monocytic, Acute 73 Congenital Abnormalities 72 Leukemia, Myelomonocytic, Acute 70 Leukemia, Erythroblastic, Acute 65 Lymphoma, Large B-Cell, Diffuse 64 Leukemia, Megakaryoblastic, Acute 62 Recurrence 58 Lymphoma, Mantle-Cell 57 Lymphoma, Follicular 41 Leukemia, Myelomonocytic, Chronic 39 Hodgkin Disease 39 Leukemia, Biphenotypic, Acute 37 Lymphoma, Large-Cell, Immunoblastic 33 Anemia, Refractory, with Excess of Blasts 30 Myeloproliferative Disorders 29 Leukemia, Lymphocytic, Chronic, B-Cell 28 Blast Crisis 28 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 27 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 23 Leukemia, Myeloid, Chronic-Phase 21 Lymphoma, B-Cell, Marginal Zone 20 Multiple Myeloma 19 Leukemia, Eosinophilic, Acute 19

Interventions

Docetaxel 244 Prednisone 196 enzalutamide 149 Leuprolide 146 Radiotherapy 139 Abiraterone Acetate 126 Magnetic Resonance Spectroscopy 123 bicalutamide 111 Goserelin 111 Androgen Antagonists 92 Radiosurgery 89 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 88 apalutamide 65 gallium 68 PSMA-11 60 abiraterone 59 Specimen Handling 59 Radiation 50 Gonadotropin-Releasing Hormone 49 darolutamide 47 cabazitaxel 43 Triptorelin Pamoate 43 Brachytherapy 43 pembrolizumab 42 Zoledronic Acid 40 Carboplatin 40 luprolide acetate gel depot 39 Estramustine 39 Biopsy 39 Standard of Care 38 Pluvicto 38

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00480090 2019-02-15

SLAP

University Health Network, Toronto

Phase 2 Completed

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡